MELBOURNE, Australia – There is a significant reduction in hospital admissions for children with asthma who used the Smartinhaler, according to a study by digital health technologies company Adherium Limited.
“This study provides good evidence that adherence monitoring with feedback can significantly improve clinical outcomes when used in the management of children with poorly controlled asthma,” said Dr. Robert Morton, lead investigator. “We would recommend this approach to be integrated into the standard care of children with poorly controlled asthma.”
The yearlong study at Sheffield Children’s Hospital included 77 children. Just over half of them used Smartinhaler adherence monitoring with medication reminders and feedback, and the rest received usual care. Drug use data were collected and children’s health outcomes were assessed at each three-month follow-up.
Adherence to prescribed medication averaged 70% in the intervention group, compared to 49% in the other group. The study found using the Smartinhaler increased medication adherence and that it was maintained over the course of 12 months. Nearly half of the children in the intervention group maintained average adherence rates of more than 80% over 12 months.
“The impact of adherence monitoring on the health of patients is clear and we continue to work with our partners to make it accessible to all those who would benefit,” said Garth Sutherland, CEO of Adherium.